Pan-Hematology Clinical Updates

A Review of the Treatment Landscape 2026

📍 Hilton Garden Inn San Juan Condado, 886 Ashford Ave, San Juan, 00907, Puerto Rico

🗓️ February 12 - 14, 2026

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the Pan-Hematology Clinical Updates Review 2026, to be held at on February 12 - 14, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing Pan-Hematology research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of Pan-Hematology Clinical Updates Meeting 2026:

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

Supporters to be announced...
Interested in supporting this meeting? Get in contact:
olivia.wright@md-education.com

Agenda & Faculty

February 12, 2026 | Day 1

8:00 AM

Registration Opens

Session I: Updates in Targeted Therapies in AML
Moderated by:

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM

IDH Mutated AML Updates

Uma Borate, MD
The Ohio State University, Ohio

9:15 AM

FLT3 Mutated AML Updates

Alexander Perl, MD
University of Pennsylvania, Philadelphia, PA

9:30 AM

Menin Inhibitor AML Updates

Joshua Zeidner, MD
UNC School of Medicine, Chapel Hill, NC

9:45 AM

Panel Discussion

10:30 AM

Coffee Break

Session II: Updates in Optimizing Frontline Therapy in Myeloid Malignancies
Moderated by:

Naval Daver, MD
MD Anderson Cancer Center, Houston, TX

10:50 AM

Intensive Chemotherapy Updates

Tapan Kadia, MD
MD Anderson Cancer Center, Houston, TX

11:05 AM

Low Intensity Therapy Updates

Eunice Wang, MD
Roswell Park Comprehensive Cancer Center, Buffalo, NY

11:20 AM

BPDCN Updates

Naveen Pemmaraju, MD
MD Anderson Cancer Center, Houston, TX

11:35 AM

Panel Discussion

12:20 PM

Lunch Break + Faculty and Fellow Photo

Session III: Updates on Upfront Therapies and CELMoDs
Moderated by:

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

1:10 PM

Updates on Smoldering Multiple Myeloma

Irene Ghobrial, MD
Dana-Farber Cancer Institute, Boston, MA

1:25 PM

Updates in Newly Diagnosed Multiple Myeloma

Saad Usmani, MD
Memorial Sloan Kettering Cancer Center, NY

1:40 PM

Updates on the Use of CELMoDs and Other Small-Molecule Inhibitors

Yuxin Liu, MD
Dana-Farber Cancer Institute, Boston, MA

1:55 PM

Panel Discussion

2:40 PM

Coffee Break

Session IV: Updates on T-Cell Redirected Therapies and ADCs
Moderated by:

Noopur Raje, MD
Massachusetts General Hospital, Boston, MA

3:00 PM

Bispecific T-Cell Engager Updates

Elizabeth O'Donnell, MD
Dana-Farber Cancer Institute, Boston, MA

3:15 PM

CAR-T Cell Therapy Updates

Krina Patel, MD
MD Anderson Cancer Center, Houston, TX

3:30 PM

Updates on Novel Combinations and ADCs

Andrew Yee, MD
Massachusetts General Hospital, Boston, MA

3:45 PM

Panel Discussion

4:30 PM

Adjourn

February 13, 2026 | Day 2

8:00 AM

Registration Opens

Session V: Updates on Aggressive and Indolent B-Cell Lymphomas
Moderated by:

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM

Newly Diagnosed DLBCL

Gilles Salles, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

9:15 AM

Relapsed DLBCL Combinations, Bispecific Abs

John Leonard, MD
NYU Langone Medical Center, New York, NY

9:30 AM

Newly Diagnosed Follicular Lymphoma, Marginal Zone Lymphoma

Fateeha Furqan, MD
MD Anderson Cancer Center, Houston, TX

9:45 AM

Panel Discussion

10:30 AM

Coffee Break

Session VI: Updates on Hodgkin, T-Cell, and Mantle Cell Lymphomas
Moderated by:

Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX

10:50 AM

Hodgkin Lymphoma

Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY

11:05 AM

Peripheral T-Cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL)

Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY

11:20 AM

Mantle Cell Lymphoma

Michael Wang, MD
MD Anderson Cancer Center, Houston, TX

11:35 AM

Panel Discussion

12:20 PM

Lunch Break + Faculty and Fellow Photo

Session VII: MDS
Moderated by:

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

1:10 PM

CHIP / CCUS

Uma Borate, MD
The Ohio State University, Comprehensive Cancer Center, Columbus, OH

1:25 PM

Lower-Risk MDS

Mikkael A. Sekeres, MD
University of Miami Miller School of Medicine, Miami, FL

1:40 PM

Higher-Risk MDS

Guillermo Garcia-Manero, MD
MD Anderson Cancer Center, Houston, TX

1:55 PM

Panel Discussion

2:40 PM

Coffee Break

Session VIII:MPN
Moderated by:

Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL

3:00 PM

Myelofibrosis

Prithviraj Bose, MD
MD Anderson Cancer Center, Houston, TX

3:15 PM

PV and ET

Gabriela Hobbs, MD
Massachusetts General Hospital, Boston, MA

3:30 PM

Mastocytosis and Other MPN

Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL

3:45 PM

Panel Discussion

4:30 PM

Adjourn

February 14, 2026 | Day 3

8:00 AM

Registration Opens

Session IX: ALL
Moderated by:

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

9:00 AM

Frontline ALL

Wendy Stock, MD
The University of Chicago Medicine, Chicago, IL

9:15 AM

Relapse Refractory ALL Novel Agents

Aaron Logan, MD
UCSF health, San Francisco, CA

9:30 AM

PH+ ALL

Nicholas Short, MD
MD Anderson Cancer Center, Houston, TX

9:45 AM

CAR-T in ALL

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

10:00 AM

T-ALL

Kristen O’Dwyer, MD
University of Rochester Medical Center, NY

10:15 PM

Panel Discussion

11:00 AM

Coffee Break

Session X: CML/CLL
Moderated by:

Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX

11:20 AM

CML Frontline

Daniel DeAngelo, MD
Dana-Farber Cancer Institute, Boston, MA

11:35 AM

CML Relapse

Michael Mauro, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

11:50 AM

CLL Frontline

William Wierda, MD
MD Anderson Cancer Center, Houston, TX

12:05 PM

CLL Relapse

William Wierda, MD
MD Anderson Cancer Center, Houston, TX

12:20 PM

Panel Discussion

1:05 PM

Adjourn

Olivia Wright
Project Manager

How long has Olivia Wright been in the business?

Olivia Wright has been with MD Education since 2025.

About Olivia Wright

As a Project Manager, I support the delivery of educational events and projects at MD Education, working closely with the project management team to ensure smooth coordination and consistently high-quality execution. With a strong background in organisation and communication, I take pride in maintaining a detail-oriented approach to my work. I am committed to delivering to a high standard and value the opportunity to be part of a team dedicated to advancing clinical education.

Pan-Hematology Clinical Updates

A Review of the Treatment Landscape 2026

Chairs of Pan-Hematology Clinical Updates Meeting 2026:

9:00 AM

Uma Borate, MDThe Ohio State University, Ohio

9:15 AM

Alexander Perl, MDUniversity of Pennsylvania, Philadelphia, PA

9:30 AM

Joshua Zeidner, MDUNC School of Medicine, Chapel Hill, NC

10:50 AM

Tapan Kadia, MDMD Anderson Cancer Center, Houston, TX

11:05 AM

Eunice Wang, MDRoswell Park Comprehensive Cancer Center, Buffalo, NY

11:20 AM

Naveen Pemmaraju, MDMD Anderson Cancer Center, Houston, TX

1:10 PM

Irene Ghobrial, MDDana-Farber Cancer Institute, Boston, MA

1:25 PM

Saad Usmani, MDMemorial Sloan Kettering Cancer Center, NY

1:40 PM

Yuxin Liu, MDDana-Farber Cancer Institute, Boston, MA

3:00 PM

Elizabeth O'Donnell, MDDana-Farber Cancer Institute, Boston, MA

3:15 PM

Krina Patel, MDMD Anderson Cancer Center, Houston, TX

3:30 PM

Andrew Yee, MDMassachusetts General Hospital, Boston, MA

9:00 AM

Gilles Salles, MDMemorial Sloan Kettering Cancer Center, New York City, NY

9:15 AM

John Leonard, MDNYU Langone Medical Center, New York, NY

9:30 AM

Fateeha Furqan, MDMD Anderson Cancer Center, Houston, TX

10:50 AM

Alison Moskowitz, MDMemorial Sloan Kettering Cancer Center, New York, NY

11:05 AM

Steven Horwitz, MDMemorial Sloan Kettering Cancer Center, New York, NY

11:20 AM

Michael Wang, MDMD Anderson Cancer Center, Houston, TX

1:10 PM

Uma Borate, MDThe Ohio State University, Comprehensive Cancer Center, Columbus, OH

1:25 PM

Mikkael A. Sekeres, MDUniversity of Miami Miller School of Medicine, Miami, FL

1:40 PM

Guillermo Garcia-Manero, MDMD Anderson Cancer Center, Houston, TX

3:00 PM

Prithviraj Bose, MDMD Anderson Cancer Center, Houston, TX

3:15 PM

Gabriela Hobbs, MDMassachusetts General Hospital, Boston, MA

3:30 PM

Andrew Kuykendall, MDMoffitt Cancer Center, Tampa, FL

9:00 AM

Wendy Stock, MDThe University of Chicago Medicine, Chicago, IL

9:15 AM

Aaron Logan, MDUCSF health, San Francisco, CA

9:30 AM

Nicholas Short, MDMD Anderson Cancer Center, Houston, TX

9:45 AM

Jae Park, MDMemorial Sloan Kettering Cancer Center, New York City, NY

10:00 AM

Kristen O’Dwyer, MDUniversity of Rochester Medical Center, NY

11:20 AM

Daniel DeAngelo, MDDana-Farber Cancer Institute, Boston, MA

11:35 AM

Michael Mauro, MDMemorial Sloan Kettering Cancer Center, New York City, NY

11:50 AM

William Wierda, MDMD Anderson Cancer Center, Houston, TX

12:05 PM

William Wierda, MDMD Anderson Cancer Center, Houston, TX

🇺🇸 MD Education USA LLC

🇬🇧 MD Education Ltd

🇦🇹 MD Education GmbH

Uma Borate, MD
The Ohio State University, Ohio

Alexander Perl, MD
University of Pennsylvania, Philadelphia, PA

Joshua Zeidner, MD
UNC School of Medicine, Chapel Hill, NC

Tapan Kadia, MD
MD Anderson Cancer Center, Houston, TX

Eunice Wang, MD
Roswell Park Comprehensive Cancer Center, Buffalo, NY

Naveen Pemmaraju, MD
MD Anderson Cancer Center, Houston, TX

Irene Ghobrial, MD
Dana-Farber Cancer Institute, Boston, MA

Saad Usmani, MD
Memorial Sloan Kettering Cancer Center, NY

Yuxin Liu, MD
Dana-Farber Cancer Institute, Boston, MA

Elizabeth O'Donnell, MD
Dana-Farber Cancer Institute, Boston, MA

Krina Patel, MD
MD Anderson Cancer Center, Houston, TX

Andrew Yee, MD
Massachusetts General Hospital, Boston, MA

Gilles Salles, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

John Leonard, MD
NYU Langone Medical Center, New York, NY

Fateeha Furqan, MD
MD Anderson Cancer Center, Houston, TX

Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY

Steven Horwitz, MD
Memorial Sloan Kettering Cancer Center, New York, NY

Michael Wang, MD
MD Anderson Cancer Center, Houston, TX

Uma Borate, MD
The Ohio State University, Comprehensive Cancer Center, Columbus, OH

Mikkael A. Sekeres, MD
University of Miami Miller School of Medicine, Miami, FL

Guillermo Garcia-Manero, MD
MD Anderson Cancer Center, Houston, TX

Prithviraj Bose, MD
MD Anderson Cancer Center, Houston, TX

Gabriela Hobbs, MD
Massachusetts General Hospital, Boston, MA

Andrew Kuykendall, MD
Moffitt Cancer Center, Tampa, FL

Wendy Stock, MD
The University of Chicago Medicine, Chicago, IL

Aaron Logan, MD
UCSF health, San Francisco, CA

Nicholas Short, MD
MD Anderson Cancer Center, Houston, TX

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

Kristen O’Dwyer, MD
University of Rochester Medical Center, NY

Daniel DeAngelo, MD
Dana-Farber Cancer Institute, Boston, MA

Michael Mauro, MD
Memorial Sloan Kettering Cancer Center, New York City, NY

William Wierda, MD
MD Anderson Cancer Center, Houston, TX

William Wierda, MD
MD Anderson Cancer Center, Houston, TX